Purchase Order 75N91024P00483
- Not listed
- This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a service agreement with a potential value of $10,217.00. The contract does not have a set-aside designation and is scheduled for completion on June 8, 2025. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, such as...
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI) to Molecular Devices LLC, a division of Danaher Corporation, for $10,217.00. The contract provides onsite performance assurance, including 1 annual preventive maintenance visit, parts, labor, and travel for repairs, as well as technical support priority response for a specialized laboratory instrument with serial number 373703698. The period of performance is from August 22, 2024 to August 21, 2025. This...
- This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $10,217.00 contract is for a maintenance agreement covering Molecular Devices' specialized bioanalytical instrumentation, software, and related services used in life sciences research, pharmaceutical development, and public health initiatives. As the original equipment manufacturer, Molecular...
- This firm-fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The $5,402.27 contract does not have a set-aside designation and is for the procurement of specialized scientific equipment and services, including microplate readers, high-content imaging systems, electrophysiology equipment, and cellular...
- This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Molecular Devices LLC, a division of Danaher Corporation. The $14,555.00 contract is for the provision of specialized laboratory equipment, software, and related services to support life sciences research, pharmaceutical development, and bioanalytical measurement. As the original equipment manufacturer, Molecular Devices LLC is...
- This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Molecular Devices LLC, a for-profit limited liability company that manufactures bioanalytical measurement solutions. The $10,217.00 maintenance agreement contract does not have a set-aside designation and has a performance period ending on March 31, 2025. Molecular Devices has previously provided specialized laboratory...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, for onsite performance assurance and one-time preventative maintenance service for the agency's Molecular Devices instruments. The contract has a ceiling value of $14,555.00 and an ultimate completion date of October 17, 2025. Molecular Devices LLC is a leading provider of bioanalytical...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $142,155.00 contract is for on-site performance assurance services for a FLIPR TETRA 96/384 molecular device system. The contract has an ultimate completion date of February 25, 2024 and was awarded on February 26, 2021. No set-aside was used for this award. Molecular Devices is a...
- This is a $24,540.00 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading manufacturer of high-performance bioanalytical measurement solutions for pharmaceutical and...
- Molecular Devices LLC was awarded a $10,217 firm fixed price purchase order for maintenance services by the National Institutes of Health's National Cancer Institute. The contract has no set-aside designation and work is to be performed in San Jose, California through March 7, 2025. As a provider of bioanalytical measurement solutions, Molecular Devices will support the National Cancer Institute's research efforts through the delivery of maintenance for laboratory instruments and equipment.
This is a $10,217 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a service agreement with an ultimate completion date of August 8, 2025. Molecular Devices is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company often receives sole-source awards as the original equipment manufacturer to provide preventative maintenance, on-site performance assurance, and repair services for its specialized laboratory instruments and software used in healthcare research, public health initiatives, and scientific studies related to areas like cancer and drug discovery. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 6/11/24 |